Autoimmune and Chronic Inflammatory Disease Patients with COVID-19.

Ryan C UngaroManasi AgrawalSarah ParkRobert HirtenJean-Frederic ColombelKathryn TwymanPercio S GulkoEyal Klang

Published in: ACR open rheumatology (2021)

Patients with AICID are not at increased risk of severe COVID-19 with the exception of those on corticosteroids. These data suggest that patients with AICID should continue on biologic and nonbiologic immunosuppression but limit steroids during the COVID-19 pandemic.

Keyphrases

coronavirus disease
drug induced
sars cov
rheumatoid arthritis
electronic health record
multiple sclerosis
oxidative stress
early onset
big data